Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Jason Gass
Data Entry Specialist
College of Medicine - Tucson
Map Page
Research Area
liver disease,
clinical trial,
clinical trials,
drug efficacy,
safety evaluation,
therapeutic intervention,
alpha-1 antitrypsin,
treatment,
safety,
drug therapy
Grants
(3)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
Active
·
2023
·
$0 / $1.6M
·
External
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevate
Active
·
2023
·
$0 / $641.6K
·
External
clinical trial,
drug therapy,
liver disease,
biomarker,
immunology
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis
Active
·
2022
·
$0 / $258.5K
·
External
clinical trials,
liver disease,
drug efficacy,
safety evaluation,
therapeutic intervention
Collaborations
(4)
Kirsten Anderson
Mutual work: 5 Proposals﹒3 Grants
Collaboration Details
Gustavo Cornejo
Mutual work: 3 Proposals﹒1 Grant
Collaboration Details
Maria Santa Cruz
Mutual work: 3 Proposals﹒1 Grant
Collaboration Details
Maria Fotinos
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
$0 / $2.5M Funding
